V
VKTX
Productby Viking Therapeutics, Inc.
Heard in 4 episodes across 1 show since Sep 2026
VKTX is the Nasdaq-listed stock ticker for Viking Therapeutics, Inc., a biopharmaceutical company developing therapies for metabolic and endocrine disorders.
Episodes
4
across 1 show
First heard
Sep 2026
Episodes per month
Public PodLume episodes featuring it, over the last year.
4
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 4 |
| Oct 2026 | 0 |
Episodes
4 episodes featuring VKTX, newest first
- Sep 24, 2026
AI optimism lifts Everpure as biotech financing rattles VikingStock MoversSep 24, 2026 - Sep 24, 2026
AI demand lifts Everpure as markets punish weaker forecastsStock MoversSep 24, 2026 - Sep 22, 2026
Alibaba, On and Viking ride distinct growth catalystsStock MoversSep 22, 2026 - Sep 22, 2026
Alibaba’s AI push meets rallies in apparel and biotechStock MoversSep 22, 2026